GlassScriptPhysician profile
Kayla Phillips
NPI 1831852235
$3,545.80
in general payments reported to CMS, 2019-2025
27 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $150 · 2022: $1,632 · 2023: $1,323 · 2024: $337 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,764.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,764.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,224.00 | 2022 | |
| Boston Scientific Corporation | $422.08 | 2022-2025 | Watchman Flx, Varithena Administration Pack |
| Merck Sharp & Dohme LLC | $242.73 | 2022-2023 | Verquvo |
| Novartis Pharmaceuticals Corporation | $169.14 | 2022-2023 | |
| Medtronic, INC. | $167.89 | 2021-2022 | |
| Edwards Lifesciences Corporation | $153.50 | 2024 | Sapien 3 Ultra Resilia |
| Astrazeneca Pharmaceuticals LP | $119.78 | 2022-2023 | Brilinta |
| Novo Nordisk INC | $119.28 | 2023 | Ozempic |
| Janssen Pharmaceuticals, INC | $111.64 | 2022-2023 | Xarelto |
| Pfizer INC. | $108.50 | 2023 | |
| Kestra Medical Technology Services, INC. | $104.70 | 2023-2024 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $101.42 | 2023 | Lifevest |
| Biosense Webster, INC. | $93.84 | 2023 | Carto 3 |
| Lexicon Pharmaceuticals, INC. | $57.74 | 2023 | Inpefa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.28 | 2022-2023 | Jardiance |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $50.75 | 2022-2023 | |
| Pacira Pharmaceuticals Incorporated | $36.72 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $31.32 | 2023 | Camzyos, Eliquis |
| Esperion Therapeutics, INC. | $23.32 | 2023 | Nexletol |
| Amarin Pharma, INC. | $21.05 | 2022 | |
| Teleflex LLC | $20.99 | 2023 | Manta |
| Inari Medical, INC. | $20.94 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Impulse Dynamics (USA) INC. | $20.83 | 2023 | Optimizer |
| Dexcom, INC. | $20.08 | 2025 | Dexcom G6 Transmitter |
| Kiniksa Pharmaceuticals, LTD. | $17.81 | 2023 | Arcalyst |
| Scpharmaceuticals INC. | $17.35 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.12 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kayla Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.